Question 40

Quarantine it at the pharmacy

When a shipment of insulin glulisine is suspected to be illegitimate, the most appropriate action is to quarantine it at the pharmacy. This step ensures that the potentially unsafe medication is isolated and prevents any further distribution or use until its legitimacy can be confirmed.

A) Return it to the original source

Returning the shipment to the original source may not be appropriate without first confirming the legitimacy of the product. This action could potentially result in the illegitimate product being sent back into the supply chain without proper verification.

B) Return it to the previous supplier

Similar to returning it to the original source, returning it to the previous supplier does not address the immediate need to contain the product. This option risks further distribution of a potentially dangerous item before its legitimacy has been established.

C) Quarantine it at the pharmacy

Quarantining the shipment is the most responsible action, as it prevents the distribution and administration of the potentially illegitimate insulin glulisine. This step allows for a thorough investigation and verification process to ensure patient safety and compliance with the Drug Supply Chain Security Act.

D) Dispose of it at the pharmacy

Disposing of the shipment may be premature without first verifying whether the insulin glulisine is indeed illegitimate. While safety is crucial, it is also important to follow the proper protocols for verifying and documenting suspected illegitimate drugs before disposal.

Conclusion

Quarantining the insulin glulisine at the pharmacy is the safest and most compliant action when a shipment is suspected to be illegitimate. This option effectively mitigates risks associated with potential misuse while allowing for further investigation, whereas the other options may lead to improper handling of the situation or unnecessary loss of medication.